1. Getz L, Sigurdsson JA, Hetlevik I. Is opportunistic disease prevention in the consultation ethically justifiable? BMJ 2003;327:498e500.
2. G  ́rvas J, Heath I, Dur  ́n A, et al; Members of the Seminar of Primary Health Innovation 2008 (Seminario de Innovaci  ́n en Atenci  ́n Primaria 2008). Clinical prevention: patients’ fear and the doctor’s guilt. Eur J Gen Pract 2009;15:122e4.
3. Whitt LA. Value-bifurcation in bioscience: the rhetoric of research justification. Perspective on Science 1999;7:413e46.
4. Pauli HG, White KL, McWhinney IR. Medical education, research, and scientific thinking in the 21st century (part one of three). Educ Health (Abingdon) 2000;13:15e25.
5. Kuhn TS. The structure of scientific revolutions. 2nd edn. Chicago: University of Chicago Press, 1970.
6. Nowotny H, Scott P, Gibbons M. Rethinking science. Knowledge and the public in an age of uncertainty. Oxford: Blackwell Publishers, 2001.
7. Funtowicz SO, Ravetz JR. Science for the post-normal age. Futures 1993;25:739e55.
8. Haraway D. Situated knowledges: the science question in feminism and the privilege of partial perspective. In: Haraway D, ed. Simians, cyborgs, and women. The reinvention of nature. New York: Routledge, 1991:182e201.
9. Kenen RH. The at-risk status and technology: a diagnostic invitation and the ‘gift’ of knowing. Soc Sci Med 1996;42:145e53.
10. Sibbald B, Bojke C, Gravelle H. National survey of job satisfaction and retirement intentions among general practitioners in England. BMJ 2003;326:22e4.
11. Freeman AC, Sweeny K. Why general practitioners do not implement evidence: a qualitative study. BMJ 2001;323:1100e2.
12. Gubb JD. Commentary: unintended consequences: what of quality outside the QOF? Br J Gen Pract 2009;59:e173e4.
13. Fisher ES, Welch HG. Avoiding the unintended consequences of growth in medical care: how might more be worse? JAMA 1999;281:446e53.
14. Reventlow SD, Hvas L, Malterud K. Making the invisible body visible. Bone scans, osteoporosis and women’s bodily experiences. Soc Sci Med 2006;62:2720e31.
15. Hofmann B. On the value-ladenness of technology in medicine. Med Health Care Philos 2001;4:335e46.
16. Hetlevik I. Evidence-based medicine in general practice: a hindrance to optimal medical care? Scand J Prim Health Care 2004;22:136e40.
17. Kirkengen AL, Ulvestad E. [Heavy burdens and complex disease e an integrated perspective] (In Norwegian). Tidsskr Nor Laegeforen 2007;127:3228e31. http:// www.tidsskriftet.no/index.php?seks_id_eng1⁄414150&seks_id1⁄41628567 (Accessed 22 Apr 2010).
18. Moynihan R, Smith R. Too much medicine? Almost certainly. BMJ 2002;324:859e60.
19. Gerv  ́s J, Starfield B, Heath I. Is clinical prevention better than cure? Lancet 2008;372:1997e9.
20. Malterud K. The legitimacy of clinical knowledge: towards a medical epidemiology embracing the art of medicine. Theor Med 1995;16:183e98.
21. McWhinney IR. Primary care: core values. Core values in a changing world. BMJ 1998;316:1807e9.
22. Patsopoulus NA, Analatos A, Ioannidis JP. Origin and funding of the most frequently cited papers in medicine: database analysis. BMJ 2006;332:1061e4.
23. Agnell M. Industry-sponsored clinical research. a broken system. JAMA 2008;300:1069e71.
24. Patel V. Cultural factors and international epidemiology. Br Med Bull 2001;57:33e45.
25. Foucault M, Gordon C. Power/knowledge: selected interviews and other writings 1972e77. Brighton: Harvester Press, 1980.
26. Dean K. The role of methods in maintaining orthodox beliefs in health research. Soc Sci Med 2004;58:675e85.
27. Royal Society, Royal Academy of Engineering. Nanosciences and Nanotechnologies: opportunities and uncertainties, 2004: 